SCHEMBL31512645

SCHEMBL31512645

O=Cc1ccc2c(c1)Oc1cc(C(F)(F)F)ccc1N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE2 Q9BYF1 1/20 0.40
▸ KIF11 P52732 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ PIM1 P11309 3/20 0.35
▸ PIM2 Q9P1W9 3/20 0.35
▸ NOX1 Q9Y5S8 2/20 0.35
▸ CYBB P04839 1/20 0.35
▸ NOX3 Q9HBY0 1/20 0.35
▸ NOX4 Q9NPH5 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ JUN P05412 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ TTR P02766 1/20 0.33
▸ CISD1 Q9NZ45 1/20 0.33
▸ ALOX5 P09917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31512648 0.93 ACE2 (0.49) ACE2KIF11ALDH1A1HSD17B10TDP1
SCHEMBL27344515 0.93 ACE2 (0.49) ACE2KIF11ALDH1A1HSD17B10TDP1
SCHEMBL30811558 0.85 ALDH1A1 (0.47) KIF11ALDH1A1HSD17B10TDP1ALOX5
SCHEMBL18448706 0.85 ACE2 (0.45) ACE2KIF11PIM1PIM2NOX1
SCHEMBL27344294 0.85 ALDH1A1 (0.47) KIF11ALDH1A1HSD17B10TDP1ALOX5
SCHEMBL31512623 0.81 ACE2 (0.38) ACE2KIF11ALDH1A1PIM1PIM2
SCHEMBL31512642 0.81 ACE2 (0.38) ACE2KIF11ALDH1A1PIM1PIM2
SCHEMBL18614108 0.78 ALOX5 (0.59) ACE2KIF11NOX1CYBBNOX3
SCHEMBL30811568 0.78 ALOX5 (0.59) KIF11ALDH1A1HSD17B10TDP1POLB
SCHEMBL30811586 0.78 KIF11 (0.49) ACE2KIF11ALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326726-A1 FERROPTOSIS INHIBITORS-PHENOXAZINE ACETAMIDES SIRONAX BEIJING CO LTD (CN) 2025-10-23 — — US disclosed
CN-119866332-A Iron death inhibitor-phenoxazine acetamides 维泰瑞隆(北京)生物科技有限公司 2025-04-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326726-A1 FERROPTOSIS INHIBITORS-PHENOXAZINE ACETAMIDES AIFM2, GPX4, FECH ACE2 1392/4885KIF11 2556/4885ALDH1A1 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback